课题基金 / 基金详情

Adhesins of uropathogenic Escherichia coli

Adhesins of uropathogenic Escherichia coli
尿路致病性大肠杆菌的粘附素
批准号:
nhmrc : 631654
负责人:
Prof Mark Schembri
金额:
$27.05万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2010
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2010-01-01 至 2013-12-31

项目摘要

项目成果

Prof Mark Schembri的其他基金

相似基金

相关文献

中文摘要
翻译
尿路感染(UTI)是人类最常见的传染病之一,也是发病率和死亡率的主要原因。在美国,UTI每年占16亿美元的医疗费用。据估计,50%的女性会在一生中患上尿路感染。这项研究旨在了解细菌在人类膀胱中定植的过程。这项工作对开发预防和治疗尿路感染的新方法具有重要意义。
英文摘要
Urinary tract infections (UTI) are among the most common infectious diseases of humans and a major cause of morbidity and mortality. In the USA, UTI accounts for >$1.6 billion in medical expenses each year. It is estimated that 50% of women will develop a UTI in their lifetime. This research aims to understand the processes by which bacteria colonize the human bladder. The work has implications for the development of new approaches to prevent and treat UTI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Untangling the matrix of bacterial biofilms
  • 批准号:
    DP230101930
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $33.22万
  • 财政年份:
    2023
  • 负责人:
    Prof Mark Schembri
  • 依托单位:
The dual-edged sword of zinc as an innate immune antimicrobial weapon against uropathogenic E. coli
  • 批准号:
    nhmrc : GNT1144967
  • 项目类别:
    Project Grants
  • 资助金额:
    $78.44万
  • 财政年份:
    2018
  • 负责人:
    Prof Mark Schembri
  • 依托单位:
The dual-edged sword of zinc as an innate immune antimicrobial weapon against uropathogenic E. coli
  • 批准号:
    nhmrc : 1144967
  • 项目类别:
    Project Grants
  • 资助金额:
    $53.04万
  • 财政年份:
    2018
  • 负责人:
    Prof Mark Schembri
  • 依托单位:
Membrane-active antibiotics against multi-drug resistant Gram negative bacteria
  • 批准号:
    nhmrc : 1106590
  • 项目类别:
    Project Grants
  • 资助金额:
    $64.88万
  • 财政年份:
    2016
  • 负责人:
    Prof Mark Schembri
  • 依托单位:
海外基金